Position in SABS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,776,831
+$892,472 QoQ
Shares Held
463,925
+96.2% QoQ
Ownership
0.510%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
11 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in SABS Over Time
Shares Held
Position Value (USD)
Derivatives in SABS
reported options exposure · as of Sep 30, 2022CallValue
$0
CallShares
247,576
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $3,014,740,742 across 267 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
543,897 | $270,169,956 | |
| 2 | INCY |
Incyte Corp
|
1,310,154 | $148,519,056 | |
| 3 | RPRX |
Royalty Pharma plc
|
2,450,669 | $137,409,009 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
991,693 | $88,042,503 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
259,799 | $78,207,292 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
1,333,207 | $75,739,488 | |
| 7 | MANE |
Veradermics, Inc
|
585,560 | $71,988,746 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
1,298,946 | $61,102,419 |
All Filings in SABS
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,776,831 | 463,925 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $884,359 | 236,460 | Shares | Other | 2026-02-13 | |
| 2024-12-31 | $1,742,083 | 459,168 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $1,239,753 | 459,168 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $1,423,420 | 459,168 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $2,084,622 | 459,168 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $3,154,674 | 4,585,282 | Shares | Other | 2024-02-14 | |
| 2022-09-30 SABSW | — | 247,576 | Call | Other | 2022-11-14 | |
| 2022-06-30 SABSW | — | 285,000 | Call | Other | 2022-08-15 | |
| 2022-03-31 SABSW | — | 285,000 | Call | Other | 2022-05-16 | |
| 2021-12-31 SABSW | — | 285,000 | Call | Other | 2022-02-14 | |
| 2021-12-31 | $3,889 | 498 | Shares | Other | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||